Stage IIIB Breast Cancer Recruiting Phase 1 Trials for Trastuzumab emtansine (DB05773)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT033643484-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast CancerTreatment